Is this you? Create Your Porfile
Avatar

L Tanganelli

University of Pisa

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where L Tanganelli is active.

Explore More

Publication

Featured researches published by L Tanganelli.

Annals of Oncology | 2000

Ovarian cancer: Optimal chemotherapy in relapsed disease.

Pf Conte; C. Cianci; L Tanganelli; Angiolo Gadducci

European Journal of Gynaecological Oncology | 2003

Is pretreatment hemoglobin level a predictor of complete response to salvage chemotherapy for recurrent platinum-pretreated ovarian carcinoma?

Angiolo Gadducci; S Cosio; A Fanucchi; L Tanganelli; Pf Conte; Renza Cristofani; Andrea R. Genazzani

Archive | 1997

Epidoxorubicin (EPIDX), carboplatin (CBDCA) and paclitaxel (PTX) in advanced epithelial ovarian cancer (AEOC)

L Tanganelli; M Galata; I Brunetti; A Romanini; F Carnino; R Yura; Angiolo Gadducci; S Mammoliti; Pf Conte

Archive | 2001

Terapia del carcinoma ovarico. B. Terapia medica.

C Bengala; Angiolo Gadducci; L Tanganelli; Pierfranco Conte

Archive | 2001

Il trattamento del carcinoma ovarico. Obiettivi della terapia e fattori prognostici e predittivi

Pf Conte; Angiolo Gadducci; L Tanganelli; Elisabetta Landucci; S Cosio; Fanucchi

Archive | 1999

p53 status and response to paclitaxel-based chemotherapy in patients with advanced epithelial ovarian cancer.

Angiolo Gadducci; Ca Cianci; F Carnino; F Buttitta; L Tanganelli; Silvana Chiara; A. R. Genazzani; Pierfranco Conte

Archive | 1999

Chemioterapia di seconda linea con ifosfamide in infusione continua in pazienti affette da carcinoma ovarico platino- resistente

L Tanganelli; A Romanini; S Cosio; A Fanucchi; A Gadducci; A. R. Genazzani; Pf Conte

Archive | 1999

Paclitaxel (TAX), carboplatin (CBDCA) and epidoxo¬rubicin (EPIDX) in advanced epithelial ovarian cancer (AEOC).

Pf Conte; C. Cianci; L Tanganelli; Angiolo Gadducci; S Cosio; F Carnino; R. Jura

Archive | 1999

Epidoxorubicin (Epidx), paclitaxel (TAX) and carboplatin (CBDCA) in advanced epithelial ovarian ancer (AEOC)

L Tanganelli; C. Cianci; Angiolo Gadducci; S Cosio; A Fanucchi; F Carnino; R Jura; Pf Conte

Archive | 1999

Combination regimen including epirubicin, paclitaxel, and carboplatin in advanced epithelial ovarian cancer: Results from a phase II study

Angiolo Gadducci; A Romanini; C. Cianci; B Ciampi; F Carnino; L Tanganelli; A. R. Genazzani; Pf Conte

Explore More

Collaboration

Dive into the L Tanganelli's collaboration.

Top Co-Authors
Avatar

F Carnino

University of Pisa

View shared research outputs
Top Co-Authors
Avatar

S Cosio

University of Pisa

View shared research outputs
Top Co-Authors
Avatar

A Fanucchi

University of Pisa

View shared research outputs
Top Co-Authors
Avatar

A. R. Genazzani

University of Pisa

View shared research outputs
Top Co-Authors
Avatar

C. Cianci

University of Pisa

View shared research outputs
Top Co-Authors
Avatar

Angiolo Gadducci

University of Pisa

View shared research outputs
Top Co-Authors
Avatar

I Brunetti

University of Pisa

View shared research outputs
Top Co-Authors
Avatar

Pierfranco Conte

University of Padua

View shared research outputs
Top Co-Authors
Avatar

Andrea R. Genazzani

University of Pisa

View shared research outputs
Top Co-Authors
Avatar

Elisabetta Landucci

University of Pisa

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge